Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Cadila gets USFDA nod for generic drug to treat Parkinson

    Cadila gets USFDA nod for generic drug to treat Parkinson

    Ruby Khatun Khatun15 Dec 2017 4:08 PM IST
    New Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
    Lupin gets USFDA nod for generic contraceptive tablets

    Lupin gets USFDA nod for generic contraceptive tablets

    Ruby Khatun Khatun15 Dec 2017 10:30 AM IST
    New Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
    Glenmark completes phase 3 study for nasal spray

    Glenmark completes phase 3 study for nasal spray

    Ruby Khatun Khatun15 Dec 2017 10:15 AM IST
    New Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
    USFDA accepts application for Indivior

    USFDA accepts application for Indivior's new schizophrenia drug

    Ruby Khatun Khatun15 Dec 2017 9:45 AM IST
    U.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
    Zydus gets USFDA nod for schizophrenia drug

    Zydus gets USFDA nod for schizophrenia drug

    Ruby Khatun Khatun11 Dec 2017 11:00 AM IST
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
    Indiabulls Pharma raises Rs 155 crore from Clermont Group

    Indiabulls Pharma raises Rs 155 crore from Clermont Group

    Ruby Khatun Khatun9 Dec 2017 2:53 PM IST
    Mumbai: Indiabulls Pharmaceuticals has raised Rs 155 crore from Singapore-based investment firm Clermont Group.Indiabulls Pharmaceuticals is a wholly...
    Dr Reddy

    Dr Reddy's gets EIR for Hyderabad facility

    Ruby Khatun Khatun4 Dec 2017 10:45 AM IST
    New Delhi: Drug firm Dr. Reddy's Laboratories today said it has received establishment inspection report (EIR) from the US health regulator for its...
    Panacea Biotec gets USFDA nod to file for generic cancer drug

    Panacea Biotec gets USFDA nod to file for generic cancer drug

    Ruby Khatun Khatun2 Dec 2017 10:00 AM IST
    New Delhi: Panacea Biotec said the US health regulator has accepted its filing for approval of generic version of cancer treatment injection...
    Securities class action lawsuit served on Dr Reddys in US

    Securities class action lawsuit served on Dr Reddys in US

    Ruby Khatun Khatun1 Dec 2017 10:41 AM IST
    New Delhi: Drug firm Dr. Reddy's Laboratories on Wednesday said it has been served a securities class action lawsuit in the US for alleged violations...
    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Zydus Cadila gets USFDA nod for blood pressure treatment drug

    Ruby Khatun Khatun30 Nov 2017 10:45 AM IST
    New Delhi: Cadila Healthcare said group firm Zydus Cadila has received final approval from the US health regulator to market Candesartan Cilexetil and...
    Zydus gets USFDA nod for seizure, migraine drug

    Zydus gets USFDA nod for seizure, migraine drug

    Ruby Khatun Khatun28 Nov 2017 1:53 PM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
    Aurobindo looks for inorganic growth prospects in East Europe

    Aurobindo looks for inorganic growth prospects in East Europe

    Ruby Khatun Khatun27 Nov 2017 10:40 AM IST
    Mumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok